UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022020
Receipt number R000025363
Scientific Title The effect of High Flow Nasal Cannula (HFNC) on end-expiratory lung volume in acute lung injury patients
Date of disclosure of the study information 2016/06/01
Last modified on 2019/11/03 17:39:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of High Flow Nasal Cannula (HFNC) on end-expiratory lung volume in acute lung injury patients

Acronym

Lung volume during HFNC

Scientific Title

The effect of High Flow Nasal Cannula (HFNC) on end-expiratory lung volume in acute lung injury patients

Scientific Title:Acronym

Lung volume during HFNC

Region

Japan


Condition

Condition

patients with acute lung injury

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of high flow nasal oxygen therapy on lung volume in the patients with acute lung injury

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

increase in end-expiratory lung volume during HFNC (high flow nasal canula)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Aplly HFNC to the patients with ALI and monitor lung volume by EIT (Electrical impedance tomograpy)for 24 hours during HFNC
Evaluate the changes in lung volume with different flow rates of HFNC (10,20,30,40,50L/min)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1)ALI (Respiratory rate >25/min, SpO2 <96%)
2)Impaired oxygenation with P/F ratio <300mmHg
3)Within 48 hours since diagnose of ALI
4)Written informed consent

Key exclusion criteria

1)Impaired lung function (COPD grade > 3, or FEV1s < 1000ml)
2)Severly impaired oxgenation with P/F ratio <150mmHg
3)Chronic heart failure (Cardiac index < 1.8L/m2, NYHA > or = 3 )
4)Unstable hemodynamics (mean arterial pressure < 50mmHg)
5)Glasgow Coma Scale <8

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Atsuko
Middle name
Last name Shono

Organization

Shimane University

Division name

Department of Anesthesiology, Faculty of medicine

Zip code

6938501

Address

Enya 89-1, Izumo city, Shimane

TEL

09094622098

Email

atsuko929shono@yahoo.co.jp


Public contact

Name of contact person

1st name atsuko
Middle name
Last name shono

Organization

Shimane University

Division name

Department of Anesthesiology, Faculty of medicine

Zip code

6938501

Address

Enya 89-1, Izumo city, Shimane

TEL

09094622098

Homepage URL


Email

atsuko929shono@yahoo.co.jp


Sponsor or person

Institute

Enya 89-1, Izumo city, Shimane

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shimane university

Address

Enya-cho 89-1 Izumo

Tel

09094622098

Email

atsuko929shono@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 01 Day


Related information

URL releasing protocol

none

Publication of results

Unpublished


Result

URL related to results and publications

none

Number of participants that the trial has enrolled

4

Results

no effect of flow rate on EELV

Results date posted

2019 Year 11 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

acute lung injury patinets

Participant flow

ALI patients included in the study

Adverse events

none

Outcome measures

no effect of flow rate on EELV

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 01 Day

Date of IRB

2016 Year 02 Month 22 Day

Anticipated trial start date

2016 Year 06 Month 01 Day

Last follow-up date

2018 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 21 Day

Last modified on

2019 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025363


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name